Authors: Lambert, JS Keefer, M Mulligan, MJ Schwartz, D Mestecky, J Weinhold, K Smith, C Hsieh, R Moldoveanu, Z Fast, P Forrest, B Koff, W

Citation: Js. Lambert et al., A Phase I safety and immunogenicity trial of UBI (R) microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects, VACCINE, 19(23-24), 2001, pp. 3033-3042